Peptides can adsorb onto syringe surfaces, reducing the actual dose delivered
Having obesity is one of the most visible diseases, and therefore it's highly stigmatized
Sterling M.R., Ferranti E.P., Green B.B., et al
A recent network meta-analysis of 117 RCTs contained estimates of the risk ratios of six separate GLP-1 RAs compared to seven separate DPP-4 inhibitors
For now, the agency is monitoring the situation
Common adverse effects of Ozempic, as documented in the UK SmPC, include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, abdominal pain (very common, affecting more than 1 in 10 patients) Decreased appetite (very common) Hypoglycaemia : when used in combination with insulin or sulphonylureas Gallbladder disorders : including cholelithiasis and cholecystitis Fatigue Injection site reactions : such as bruising or pain Whilst musculoskeletal pain is not formally listed, healthcare professionals should remain vigilant for patient reports and consider the broader context of treatment, including weight loss trajectory, nutritional status, and concurrent medical conditions